Sarepta Therapeutics Inc (SRPT) — Cash Flow-to-Debt Ratio
Sarepta Therapeutics Inc (SRPT) has a Cash Flow-to-Debt Ratio of -0.12x as of March 2026, meaning its operating cash flow of $-202.68 Million could theoretically repay 0% of its total liabilities ($1.67 Billion) in one year. See Sarepta Therapeutics Inc (SRPT) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sarepta Therapeutics Inc Cash Flow-to-Debt Ratio (1995–2025)
Historical debt coverage capacity for Sarepta Therapeutics Inc across 31 annual periods. Also explore Sarepta Therapeutics Inc (SRPT) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Sarepta Therapeutics Inc (1995–2025)
Year-by-year debt coverage analysis for Sarepta Therapeutics Inc. For market capitalisation and broader financial context, see market value of Sarepta Therapeutics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.09x | $-205.48 Million | $2.21 Billion | ▼ -10.1% |
| 2024 | -0.08x | $-205.79 Million | $2.44 Billion | ▲ +59.4% |
| 2023 | -0.21x | $-500.99 Million | $2.41 Billion | ▼ -75.6% |
| 2022 | -0.12x | $-325.35 Million | $2.74 Billion | ▲ +40.6% |
| 2021 | -0.20x | $-443.17 Million | $2.22 Billion | ▼ -512.9% |
| 2020 | 0.05x | $107.47 Million | $2.22 Billion | ▲ +110.6% |
| 2019 | -0.45x | $-456.46 Million | $1.00 Billion | ▲ +28.7% |
| 2018 | -0.64x | $-388.66 Million | $609.80 Million | ▼ -42.5% |
| 2017 | -0.45x | $-232.00 Million | $518.75 Million | ▲ +84.1% |
| 2016 | -2.81x | $-245.82 Million | $87.41 Million | ▼ -57.0% |
| 2015 | -1.79x | $-149.47 Million | $83.44 Million | ▲ +34.0% |
| 2014 | -2.71x | $-128.54 Million | $47.38 Million | ▼ -86.1% |
| 2013 | -1.46x | $-64.69 Million | $44.38 Million | ▼ -299.2% |
| 2012 | -0.37x | $-29.69 Million | $81.31 Million | ▲ +64.0% |
| 2011 | -1.01x | $-23.68 Million | $23.35 Million | ▼ -225.3% |
| 2010 | -0.31x | $-15.21 Million | $48.79 Million | ▼ -28.9% |
| 2009 | -0.24x | $-8.80 Million | $36.40 Million | ▲ +80.8% |
| 2008 | -1.26x | $-12.34 Million | $9.80 Million | ▲ +37.5% |
| 2007 | -2.01x | $-24.68 Million | $12.26 Million | ▲ +69.2% |
| 2006 | -6.54x | $-20.61 Million | $3.15 Million | ▼ -22.6% |
| 2005 | -5.34x | $-14.67 Million | $2.75 Million | ▲ +49.5% |
| 2004 | -10.57x | $-23.78 Million | $2.25 Million | ▼ -126.8% |
| 2003 | -4.66x | $-17.48 Million | $3.75 Million | ▼ -17.8% |
| 2002 | -3.96x | $-20.26 Million | $5.12 Million | ▼ -1.2% |
| 2001 | -3.91x | $-12.82 Million | $3.28 Million | ▲ +26.2% |
| 2000 | -5.30x | $-9.13 Million | $1.72 Million | ▲ +30.3% |
| 1999 | -7.60x | $-7.60 Million | $1.00 Million | ▼ -36.1% |
| 1998 | -5.58x | $-6.70 Million | $1.20 Million | ▲ +6.9% |
| 1997 | -6.00x | $-3.00 Million | $500.00K | ▼ -1175.0% |
| 1996 | -0.47x | $-1.60 Million | $3.40 Million | ▲ +92.1% |
| 1995 | -5.93x | $-1.78 Million | $300.00K | — |